Skip to main content
SRES 251 113th Congress Senate

A resolution expressing the sense of the Senate that the United States Preventive Services Task Force should reevaluate its recommendations against prostate-specific antigen-based screening for…

Official title: A resolution expressing the sense of the Senate that the United States Preventive Services Task Force should reevaluate its recommendations against prostate-sp… Show full official titleShow less

Official title: A resolution expressing the sense of the Senate that the United States Preventive Services Task Force should reevaluate its recommendations against prostate-specific antigen-based screening for prostate cancer for men in all age groups in consultation with appropriate specialists.

Introduced: October 30, 2013 See on congress.gov
Health CancerHealth promotion and preventive careMedical researchMedical tests and diagnostic methods
This resolution expired with the 113th Congress
It was not agreed to before the 113th Congress (2013–2014) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Agreed to (Senate)
Sep 23, 2013
Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S6684-6685)
Sep 23, 2013
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action September 23, 2013

Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S6684-6685)

 Plain-English summary Congressional Research Service

Calls for the U.S. Preventive Services Task Force to: (1) reevaluate its recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups, (2) seriously engage and consult with specialists as it reevaluates its recommendation, and (3) identify areas for additional research and evaluation of methods of treatment of, and screening procedures for, prostate cancer.

Expresses the sense of the Senate that: (1) prostate cancer screening decisions should be made by each individual patient and his physician, taking into account the patient's risk factors and desire for treatment; and (2) steps should be taken to raise awareness of, and increase public knowledge about, prostate cancer, the benefits of early detection, and the appropriateness of screening tests.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. Res. 251: A resolution expressing the sense of the Senate that the United States Preventive Services Task Force should reevaluate its recommendations against prostate-specific antigen-based screening for prostate cancer for men in all age groups in consultation with appropriate specialists.. 113th Congress. Open America. https://openamerica.io/bill/113-SRES-251/
MLA
"S. Res. 251: A resolution expressing the sense of the Senate that the United States Preventive Services Task Force should reevaluate its recommendations against prostate-specific antigen-based screening for prostate cancer for men in all age groups in consultation with appropriate specialists.." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-SRES-251/.
Bluebook (legal)
S. Res. 251, 113th Cong. (2026), https://openamerica.io/bill/113-SRES-251/.
Markdown link
[S. Res. 251: A resolution expressing the sense of the Senate that the United States Preventive Services Task Force should reevaluate its recommendations against prostate-specific antigen-based screening for prostate cancer for men in all age groups in consultation with appropriate specialists.](https://openamerica.io/bill/113-SRES-251/)
Report a problem